pharma news today obesity glp-1 The Multi-Sector Impacts of GLP-1RA Drugs Could weight-loss drugs eat the

The genetics of gout: towards personalised medicine

15, 16 GLP-1, endogenously produced in the L-cells of the distal ileum and colon, modulates appetite leading to decreased food intake and thus body weight

If a patient presents with severe hyperglycemia or an A1C level of 10% or greater, the ADA recommends that insulin therapy be strongly considered as initial therapy

Across all characteristics, there were no significant differences observed between patients with low and normal free carnitine levels at baseline

Were now seeing great results with low-dose oral minoxidil

Endotoxin-Screened BPC-157 Independently accredited by the US laboratory BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide made up of 15 amino acids